Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Thomas G. Knight, MD, Myra Robinson, MS, Jing Ai, MD PhD, Brittany K Ragon, MD, Rhonda Davis, RN, BSN, Cindy Shiflett, LPN, Erica Ruston, RN, BSN, Hailey Glover, RN, BSN, Jigar Trivedi, MSc, PharmD, Belinda R Avalos, MD, Jonathan M. Gerber, MD, James T Symanowski, PhD, Edward A Copelan, Michael R. Grunwald, MD

Blood (2019) 134 (Supplement_1): 2099.

https://doi.org/10.1182/blood-2019-128858

Published: 2019

Journal Articles

Comparison of Biologically Assigned HLA-Identical Versus Haploidentical Related Donor Hematopoietic Stem Cell Transplantation

Blood (2017) 130 (Supplement 1): 4605.

https://doi.org/10.1182/blood.V130.Suppl_1.4605.4605

Published: 2017

Journal Articles

AcDVP16 Induction Therapy for Acute Myeloid Leukemia

Michael Richard Grunwald, MD, Amy M. Ellenburg, PharmD, Michael Keith Allister Zimmerman, MS, Jing Ai, MD PhD, Thomas G. Knight, MD, Lauren M. Bohannon, Danielle Boselli, MS, Jigar Trivedi, MSc, PharmD, Margaret A. Croom, PharmD, William E. Anderson, JD, MS, James T Symanowski, PhD, Edward A Copelan, MD, Dragos Plesca, PharmD, Jonathan M. Gerber, MD

Blood (2017) 130 (Supplement 1): 3902.

https://doi.org/10.1182/blood.V130.Suppl_1.3902.3902

Published: 2017

Journal Articles

Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia

Michael Richard Grunwald, MD, Michael Keith Allister Zimmerman, MS, Danielle Boselli, MS, Lauren M. Bohannon, Myra M Robinson, MSPH, Daniel T. Peters, Jing Ai, MD PhD, Thomas G. Knight, MD, Jigar Trivedi, MSc, PharmD, Dragos Plesca, PharmD, James T Symanowski, PhD, Edward A Copelan, MD, Jonathan M. Gerber, MD

Blood (2017) 130 (Supplement 1): 3864.

https://doi.org/10.1182/blood.V130.Suppl_1.3864.3864

Published: 2017

Journal Articles

A Novel Approach to Identify a Putative Leukemia Stem Cell Population in Acute Lymphocytic Leukemia (ALL) and Distinguish Philadelphia Chromosome-Positive ALL from Lymphoid Blast Crisis Chronic Myeloid Leukemia

Jonathan M. Gerber, MD, Lawrence J. Druhan, PhD, David Foureau, PhD, Elizabeth Jandrisevits, Amanda Lance, BS, Andrea E. Price, BS, Virginia Thurston, PhD, Jing Ai, MD PhD, Michael R. Grunwald, MD, Edward H. Lipford, MD, Belinda R. Avalos, MD

Blood (2016) 128 (22): 2912.

https://doi.org/10.1182/blood.V128.22.2912.2912

Published: 2016

Journal Articles

Impact of Non- JAK2 Molecular Mutations and Cryptic SNP Lesions in Myelofibrosis Patients Treated with Ruxolitinib

Jing Ai, MD PhD, Valeria Visconte, PhD, Ali Tabarroki, MD, Ahmad Zarzour, MD, Christopher Gerace, Karam Al-Issa, MD, Evan Hsi, Yasmine Hirbawi, Betty K. Hamilton, MD, Eric D. Hsi, MD, Heesun J. Rogers, MD PhD, Ramon V. Tiu, MD

Blood (2014) 124 (21): 3194.

https://doi.org/10.1182/blood.V124.21.3194.3194

Published: 2014

Journal Articles

Impact of Day 28 Absolute Lymphocyte Count on Outcome of Adult Patients with Acute Myeloid Leukemia

Naresh Bumma, MD, Jing Ai, MD PhD, Xuefei Jia, MS, Sean Hobson, MA, Donna Abounader, Mikkael A. Sekeres, MD MS, Matt E. Kalaycio, MD, Ron Sobecks, MD, Aaron Gerds, MDMS, Betty K. Hamilton, MD, Sudipto Mukherjee, MD PhD MPH, Hetty E. Carraway, MD, Shawnda Tench, Edward A. Copelan, MD, Anjali S. Advani, MD

Blood (2014) 124 (21): 5256.

https://doi.org/10.1182/blood.V124.21.5256.5256

Published: 2014

Journal Articles

Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib

Ahmad Zarzour, MD, Ali Tabarroki, MD, Valeria Visconte, PhD, Rokana Taftaf, MD, Heesun J. Rogers, MD PhD, Jing Ai, MD PhD, Nikolaos Papadantonakis, MD PhD, Alan E. Lichtin, Yogen Saunthararajah, MD, Brady L Stein, MDMHS, Ramon V. Tiu, MD

Blood (2014) 124 (21): 1834.

https://doi.org/10.1182/blood.V124.21.1834.1834

Published: 2014

Journal Articles

Rates of Infection in Myelofibrosis Patients Treated with Ruxolitinib

Ahmad Zarzour, MD, Ali Tabarroki, MD, Rokana Taftaf, MD, Valeria Visconte, PhD, Jing Ai, MD PhD, Betty K. Hamilton, MD, Nikolaos Papadantonakis, MD PhD, Alan E. Lichtin, Leonard J. Horwitz, MD, Anjali S. Advani, MD, Mikkael A. Sekeres, MD MS, Ramon V. Tiu, MD

Blood (2014) 124 (21): 1835.

https://doi.org/10.1182/blood.V124.21.1835.1835

Published: 2014

Journal Articles

Nitric Oxide As a Mediator of Bone Marrow Fibrosis in Patients with Myelofibrosis

Ali Tabarroki, MD, Daniel Lindner, MD PhD, Valeria Visconte, PhD, Nikolaos Papandantonakis, Jing Ai, MD PhD, Mikkael A. Sekeres, MD MS, Anjali S. Advani, MD, Matt E. Kalaycio, MD, Tracy Cinalli, RN, Kristin Colaluca, RN, Gina Rupp, John Desamito, Heesun J. Rogers, MD PhD, Ramon V. Tiu, MD

Blood (2014) 124 (21): 4587.

https://doi.org/10.1182/blood.V124.21.4587.4587

Published: 2014

Journal Articles

Spliceosome Mutations Are Frequent In Patients With Myelodysplastic Syndromes Who Failed Hypomethylating Therapy: Possible Implications Of Spliceosome Inhibitors As Alternative Treatments

Valeria Visconte, PhD, Fabiola Traina, MD, PhD, Ali Tabarroki, MD, Edy Hasrouni, Jing Ai, MD, PhD, Matt Kalaycio, MD, Anjali S. Advani, MD, Hien K. Duong, MD, Yogen Saunthararajah, M.D., John Barnard, Mikkael A. Sekeres, MD, MS, Ramon V. Tiu, MD

Blood (2013) 122 (21): 5237.

https://doi.org/10.1182/blood.V122.21.5237.5237

Published: 2013

Journal Articles

Poor Survival Outcomes In Myelodysplastic Syndrome Patients With Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Influenced By SRSF2 Mutations

Jing Ai, MD, PhD, Valeria Visconte, PhD, Ali Tabarroki, MD, Edy Hasrouni, Betty K. Hamilton, MD, Sudipto Mukherjee, MD, PhD, MPH, Matt Kalaycio, MD, Ronald M. Sobecks, MD, Anjali S. Advani, MD, Mikkael A. Sekeres, MD, MS, Shashirekha Shetty, PhD, Ramon V. Tiu, MD

Blood (2013) 122 (21): 2809.

https://doi.org/10.1182/blood.V122.21.2809.2809

Published: 2013

Journal Articles

Modified Dose Escalation Of Ruxolitinib: A Feasible Therapeutic Approach In The Management Of Myelofibrosis

Ali Tabarroki, MD, Daniel Lindner, Valeria Visconte, PhD, Heesun J. Rogers, MD, PhD, John Desamito, Hien K. Duong, MD, Alan E. Lichtin, Anjali S. Advani, MD, Ronald M. Sobecks, MD, Tracy Cinalli, RN, Kristin Dodd, RN, Jing Ai, MD, PhD, Yogen Saunthararajah, M.D., Matt Kalaycio, MD, Brady L. Stein, MD, Mikkael A. Sekeres, MD, MS, Ramon V. Tiu, MD

Blood (2013) 122 (21): 1586.

https://doi.org/10.1182/blood.V122.21.1586.1586

Published: 2013

NARROW

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Comparison of Biologically Assigned HLA-Identical Versus Haploidentical Related Donor Hematopoietic Stem Cell Transplantation

AcDVP16 Induction Therapy for Acute Myeloid Leukemia

Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia

A Novel Approach to Identify a Putative Leukemia Stem Cell Population in Acute Lymphocytic Leukemia (ALL) and Distinguish Philadelphia Chromosome-Positive ALL from Lymphoid Blast Crisis Chronic Myeloid Leukemia

Impact of Non- JAK2 Molecular Mutations and Cryptic SNP Lesions in Myelofibrosis Patients Treated with Ruxolitinib

Impact of Day 28 Absolute Lymphocyte Count on Outcome of Adult Patients with Acute Myeloid Leukemia

Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib

Rates of Infection in Myelofibrosis Patients Treated with Ruxolitinib

Nitric Oxide As a Mediator of Bone Marrow Fibrosis in Patients with Myelofibrosis

Spliceosome Mutations Are Frequent In Patients With Myelodysplastic Syndromes Who Failed Hypomethylating Therapy: Possible Implications Of Spliceosome Inhibitors As Alternative Treatments

Poor Survival Outcomes In Myelodysplastic Syndrome Patients With Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Influenced By SRSF2 Mutations

Modified Dose Escalation Of Ruxolitinib: A Feasible Therapeutic Approach In The Management Of Myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only